Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Search
Sign in
Sign up
CS
Credit Suisse’s
4D Molecular Therapeutics
FDMT
Stock Holding History
Credit Suisse’s Portfolio
FDMT Stock Details
FDMT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter
Market Value
Status
Shares
Change in
Stake
Trade Value
Portfolio Weight
Portfolio Position
2024
Q1
$765K
Buy
2023
Q4
$452K
Sell
2023
Q3
$328K
Sell
2023
Q2
$626K
Buy
2023
Q1
$231K
Buy
2022
Q4
$22
Sell
2022
Q3
$141K
Buy
2022
Q2
$122K
Sell
2022
Q1
$282K
Buy
2021
Q4
$329K
Buy
2021
Q3
$241K
Buy
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Theme
Close